Compare

Magnera Corp/$MAGN

1D1W1M3M6MYTD1Y5YMAX

About Magnera Corp

Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.
Ticker
$MAGN
Sector
Materials
Primary listing
NYSE
Employees
-

Magnera Corp Metrics

BasicAdvanced
$442M
-
-$3.14
-
-

What the Analysts think about Magnera Corp

Analyst ratings (Buy, Hold, Sell) for Magnera Corp stock.
Analyst projections of the future price of Magnera Corp stock.

Bulls say / Bears say

Third-quarter adjusted EBITDA rose 9% to $99 million, alongside 1% organic volume growth. Magnera credited merger synergies and Project CORE savings, suggesting the integration is beginning to improve operating performance. (Magnera)
Magnera reduced debt by $51 million from fiscal year-end to June and maintained its full-year free cash flow outlook of $90 million to $110 million. If it delivers that cash, it could keep paying down debt. (SEC)
A new German production line expands Magnera’s ability to make specialist films for personal care and healthcare, while a research agreement on battery separators offers longer-term product optionality. Neither initiative yet proves a material revenue contribution. (Magnera, Magnera)
Magnera still carries about $1.9 billion of debt. Its $37 million quarterly interest bill helped leave it with a $20 million net loss, showing how debt costs constrain shareholder earnings. (SEC)
Raw-material inflation accelerated, and price increases took time to catch up, particularly outside the Americas. Management expects full-year adjusted EBITDA towards the lower end of its previous guidance range, despite savings initiatives. (Magnera)
Demand softness in Europe weighed on Magnera’s Rest of World business, where adjusted EBITDA fell year on year. Continued regional weakness could limit the benefits of cost savings and pricing actions. (The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 15 Oct 2026.

Magnera Corp Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Magnera Corp Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Magnera Corp

Funds
Fund name
Fund size
$MAGN weighting
SPDR Russell 2000 US Small Cap€R2US
$5.3B0.02%
SPDR Russell 2000 US Small Cap£R2SC
$5.3B0.02%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.